We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
+11.91%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
10 Year Est. Return
AUM
$140M
AUM Growth
+$20.4M
Cap. Flow
+$6.42M
Cap. Flow %
4.57%
Top 10 Hldgs %
100%
Holding
3
New
Increased
2
Reduced
1
Closed

Top Buys

Rank Stock Value
1
OLLI icon
Ollie's Bargain Outlet
OLLI
+$9.5M
2
AZTA icon
Azenta
AZTA
+$6.3M

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$9.39M

Sector Composition

Rank Sector Weight
1 Healthcare 74.42%
2 Consumer Staples 25.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO icon
1
Bio-Rad Laboratories Class A
BIO
$8.15B
$60.5M 43.05%
163,379
-26,621
-14% -$9.39M
AZTA icon
2
Azenta
AZTA
$1.21B
$44.1M 31.37%
1,050,000
+150,000
+17% +$6.3M
OLLI icon
3
Ollie's Bargain Outlet
OLLI
$4.02B
$35.9M 25.58%
550,000
+150,000
+38% +$9.5M

Similar funds

Tower House Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Tower House Partners held 3 positions worth $140M, up 17% from $120M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners deployed $6.42M of net new capital in Q4 2019, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 80% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was Bio-Rad Laboratories Class A, an estimated $9.39M trimmed.

  • Tower House Partners added most to Ollie's Bargain Outlet in Q4 2019, an estimated $9.5M increase.
  • Tower House Partners's biggest Q4 2019 reduction was Bio-Rad Laboratories Class A, cutting an estimated $9.39M.
  • Tower House Partners's ten largest holdings make up 100% of its $140M portfolio in Q4 2019.
  • Tower House Partners opened 0 new positions and closed 0 in Q4 2019.
  • Tower House Partners's portfolio value rose 17% quarter-over-quarter to $140M.

Based on Tower House Partners's 13F filing for Q4 2019, filed 12 Feb 2020.